Report on Psychedelics

Conversations: JR Rahn, MindMed

Episode Summary

Mindmed is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. We spoke with co-CEO JR Rahn about his path as an entrepreneur, the company’s approach to tackling the opioid crisis and their intellectual property strategy.

Episode Notes

Learn more about MindMed at their website:

Stay up to date with the latest in the business of psychedelics by subscribing to our weekly briefing:

Our Conversations Podcast is supported by the NEO Exchange. With a focus on fairness, liquidity, efficiency and unparalleled client service, the NEO Exchange creates a better public listing experience by doing what’s right for investors and capital-raisers. Learn why NEO is the next generation stock exchange  at